Cerus Corp (NASDAQ: CERS) kicked off on Tuesday, down -1.38% from the previous trading day, before settling in for the closing price of $1.45. Over the past 52 weeks, CERS has traded in a range of $1.38-$2.54.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 15.20% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 15.91%. With a float of $173.26 million, this company’s outstanding shares have now reached $185.77 million.
In an organization with 281 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 55.21%, operating margin of -13.7%, and the pretax margin is -11.51%.
Cerus Corp (CERS) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Cerus Corp is 6.75%, while institutional ownership is 76.28%. The most recent insider transaction that took place on Mar 14 ’25, was worth 43,609. In this transaction Chief Legal Officer of this company sold 30,075 shares at a rate of $1.45, taking the stock ownership to the 783,294 shares. Before that another transaction happened on Mar 13 ’25, when Company’s Chief Legal Officer sold 18,949 for $1.45, making the entire transaction worth $27,476. This insider now owns 813,369 shares in total.
Cerus Corp (CERS) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 15.91% per share during the next fiscal year.
Cerus Corp (NASDAQ: CERS) Trading Performance Indicators
Take a look at Cerus Corp’s (CERS) current performance indicators. Last quarter, stock had a quick ratio of 1.79. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.47. Likewise, its price to free cash flow for the trailing twelve months is 31.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.11, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach -0.01 in one year’s time.
Technical Analysis of Cerus Corp (CERS)
Let’s dig in a bit further. During the last 5-days, its volume was 1.96 million. That was better than the volume of 1.55 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 24.47%. Additionally, its Average True Range was 0.10.
During the past 100 days, Cerus Corp’s (CERS) raw stochastic average was set at 5.85%, which indicates a significant decrease from 16.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.12% in the past 14 days, which was lower than the 64.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7106, while its 200-day Moving Average is $1.8429. However, in the short run, Cerus Corp’s stock first resistance to watch stands at $1.4733. Second resistance stands at $1.5167. The third major resistance level sits at $1.5633. If the price goes on to break the first support level at $1.3833, it is likely to go to the next support level at $1.3367. Assuming the price breaks the second support level, the third support level stands at $1.2933.
Cerus Corp (NASDAQ: CERS) Key Stats
The company with the Market Capitalisation of 265.68 million has total of 185,790K Shares Outstanding. Its annual sales at the moment are 201,320 K in contrast with the sum of -20,920 K annual income. Company’s last quarter sales were recorded 56,750 K and last quarter income was -2,520 K.
